colistimethate sodium
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Colorado, Denver
Overview
colistimethate sodium is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
colistimethate sodium clinical trials
Explore related
Medical disclaimer. This page summarizes research about colistimethate sodium for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.